Amgen Inc (AMGN · NASDAQ)

AMGN · MARKET VIEW

Market view · as of Jun 22, 2026

Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
60.6%
-12.4% vs 52w high · +1.8% 1mo

Price (last ~year)

Amgen Inc. (AMGN) reported first-quarter 2026 earnings of $5.15 per share, exceeding analyst estimates of $4.77, on quarterly revenue of $8.62 billion. The stock is currently trading at $337.60, representing a 1.8% gain over the past month and a market capitalization of $182.21 billion. With a P/E ratio of 23.48 and an analyst price target of $352.77, the company maintains $57.32 billion in total debt, resulting in a 3.4x debt-to-EBITDA ratio.

Valuation

Market cap
$182.21B
P/E
23.48
PEG
2.231
P/B
19.83
P/S
4.895
EV/EBITDA
13.65
Beta
0.416
Analyst target
$352.77

Quality & returns

Gross margin
71.4%
Operating margin
33.8%
Profit margin
21.0%
ROE
101.3%
ROA
8.3%

Price movement

Last
$337.60
1-month
+1.8%
3-month
-2.4%
RSI (14)
51
vs SMA200
+3.0%
52-wk position
60.6% -12.4% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$8.62B$2.67B$1.82B$3.86B
2025-12-31$9.90B$3.94B$1.33B$3.30B
2025-09-30$9.56B$2.53B$3.22B$5.91B
2025-06-30$9.17B$2.64B$1.43B$3.62B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots